Clinical CPD Library
1 of 3

17. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea

Download hereย 

CEUs: 2 Clinical

Average read time: 75 minutes.

Short Summary of the Article:

The article is an updated guideline from the American Gastroenterological Association (AGA) focusing on the pharmacological management of Irritable Bowel Syndrome with predominant diarrhea (IBS-D). It outlines various pharmacological agents like eluxadoline, rifaximin, alosetron, and others, reviewing their efficacy, dosage, and potential adverse effects. The guidelines are intended for clinicians and provide evidence-based recommendations using the GRADE framework

 

Learning Outcomesย 

Upon completion of this activity, you should have an understanding of:

  1. The key pharmacological treatments recommended for managing IBS-D and their clinical application.
  2. The risks and benefits associated with each treatment option, including potential adverse effects.
  3. How to apply shared decision-making principles in treating IBS-D patients, especially when conditional recommendations are present

 

(Max of 3 Attempts)

Ryshane Sewpersad

Please Contact Us For More Details

health and safety training

If you would like to know more about our INRAsafe Accredited Courses please contact us below